Itolizumab, a monoclonal antibody developed by the Center of Molecular Immunology (CIM) in collaboration with Biocon, India's largest pharmaceutical company,…
Established in 1991, the Center of Molecular Immunology (Centro de Inmunologia Molecular) (CIM) situated in Playa, west of Havana, is…
CimaVax-EGF, the lung cancer vaccine developed by Cuba’s Center of Molecular Immunology is the very first therapeutic cancer vaccine. It…